TABLE 2.
A | ||||
GenBank accession | GeneSymbol | Target position of probe on CpG island microarray | mRNA | DNA methylation |
---|---|---|---|---|
Fold change | Fold change of relative methylation | |||
NM_001161855 | 4933416C03Rik | chr10:115551150–115551194 | 0.165 | 2.153 |
NM_008532 | Epcam | chr17:88039798–88039842 | 0.013 | 1.729 |
NM_008192 | Gucy2e | chr11:69049315–69049359 | 0.105 | 1.541 |
NR_027967 | Hhatl | chr9:121698137–121698187 | 0.600 | 2.288 |
NM_213729 | Inca1 | chr11:70513486–70513530 | 0.196 | 1.704 |
NM_027397 | Isl2 | chr9:55394278–55394322 | 0.045 | 1.522 |
NM_001033250 | Lemd1 | chr1:134086976–134087020 | 0.188 | 1.840 |
NM_015743 | Nr4a3 | chr4:48060289–48060333 | 0.056 | 2.393 |
NM_008814 | Pdx1 | chr5:148081815–148081859 | 0.078 | 1.623 |
NM_009027 | Rasgrf2 | chr13:92901976–92902020 | 0.263 | 3.225 |
NM_001164704 | Renbp | chrX:71167531–71167575 | 0.199 | 3.621 |
NM_001033415 | Shisa3 | chr5:67999755–67999799 | 0.306 | 1.502 |
NM_173429 | Zfp775 | chr6:48569751–48569795 | 0.664 | 1.528 |
NM_173429 | Zfp775 | chr6:48570111–48570155 | 0.664 | 1.549 |
NM_173429 | Zfp775 | chr6:48570207–48570251 | 0.664 | 2.012 |
NM_173429 | Zfp775 | chr6:48570342–48570386 | 0.664 | 2.204 |
B | ||||
GenBank accession | GeneSymbol | Target position of probe on CpG island microarray | mRNA | DNA methylation |
---|---|---|---|---|
Fold change | Fold change of relative methylation | |||
NR_024323 | 4930426L09Rik | chr2:18919881–18919925 | 0.221 | 1.977 |
NM_026185 | Abhd15 | chr11:77328807–77328851 | 0.058 | 1.661 |
NM_009681 | Ap3s1 | chr18:46901926–46901970 | 0.541 | 2.070 |
NM_001163614 | Ascl4 | chr10:85391455–85391499 | 0.513 | 1.767 |
NM_001163614 | Ascl4 | chr10:85391524–85391568 | 0.513 | 1.602 |
NM_016709 | Auh | chr13:53024981–53025025 | 0.247 | 1.692 |
NM_009877 | Cdkn2a | chr4:88940707–88940751 | 0.084 | 1.630 |
NM_007760 | Crat | chr2:30271133–30271177 | 0.144 | 2.214 |
NR_028264 | Dleu2 | chr14:62301793–62301837 | 0.066 | 2.086 |
NR_028264 | Dleu2 | chr14:62305865–62305909 | 0.066 | 1.558 |
NR_028264 | Dleu2 | chr14:62300358–62300402 | 0.066 | 1.526 |
NM_133763 | Dnttip1 | chr2:164571271–164571315 | 0.282 | 1.520 |
NM_027828 | Fam110c | chr12:31758655–31758699 | 0.105 | 1.608 |
NM_015821 | Fbxl8 | chr8:107788500–107788544 | 0.374 | 1.752 |
NM_018789 | Foxo4 | chrX:98450245–98450289 | 0.134 | 1.854 |
NM_010340 | Gpr50 | chrX:68917753–68917797 | 0.045 | 1.609 |
NM_010468 | Hoxd3 | chr2:74578542-74578586 | 0.371 | 1.809 |
NM_010468 | Hoxd3 | chr2:74550322–74550366 | 0.371 | 1.619 |
NM_028708 | Jakmip3 | chr7:146132486–146132530 | 0.036 | 4.012 |
NM_001033430 | Jhdm1d | chr6:39155596–39155640 | 0.122 | 2.359 |
NM_001033430 | Jhdm1d | chr6:39157044–39157088 | 0.122 | 1.774 |
NM_001037712 | Kcnh6 | chr11:105881863–105881907 | 0.153 | 1.967 |
NM_030716 | Kcnip2 | chr19:45890581–45890625 | 0.500 | 1.823 |
NM_152895 | Kdm5b | chr1:136457792–136457836 | 0.227 | 1.678 |
NM_023061 | Mcam | chr9:43943262–43943306 | 0.444 | 2.490 |
NM_001122667 | Mkl2 | chr16:13256418–13256462 | 0.100 | 1.806 |
NM_181860 | Mkl2 | chr16:13257041–13257085 | 0.100 | 1.574 |
NM_011037 | Pax2 | chr19:44830746–44830790 | 0.044 | 1.621 |
NM_001162929 | Pom121l2 | chr13:22073387–22073431 | 0.142 | 1.679 |
NM_001123362 | Prdm12 | chr2:31495757–31495801 | 0.420 | 1.676 |
NM_001164570 | Rffl | chr11:82684465–82684509 | 0.474 | 1.706 |
NM_017395 | Rfx5 | chr3:94758251–94758295 | 0.221 | 1.892 |
NM_019732 | Runx3 | chr4:134708685–134708729 | 0.531 | 1.612 |
NM_011432 | Snrpc | chr17:27977231–27977275 | 0.482 | 1.763 |
NM_054103 | Stk33 | chr7:116582357–116582401 | 0.387 | 1.933 |
NM_011517 | Sycp3 | chr10:87922666–87922710 | 0.427 | 1.532 |
NM_009331 | Tcf7 | chr11:52096304–52096348 | 0.104 | 1.611 |
NM_001085555 | Tcp11 | chr17:28217573–28217617 | 0.066 | 2.106 |
NM_013687 | Tcp11 | chr17:28217206–28217250 | 0.066 | 1.703 |
NR_001463 | Xist | chrX:100677336–100677380 | 0.050 | 1.721 |
NR_001463 | Xist | chrX:100677473–100677517 | 0.050 | 1.547 |
The threshold value used to designate altered mRNA expression or DNA methylation was a fold change of ≥1.5 or ≤0.67.